The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differentiated activity profile for the PD-1 inhibitor balstilimab.
 
Cailin Joyce
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
Dhan Chand
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
Benjamin Duckless
Employment - Agenus
 
Manuel Hidalgo
Stock and Other Ownership Interests - Agenus; BioOncotech; Champions Oncology; Nelum Corp.; Pharmacyte Biotech
Honoraria - Agenus; InxMed; Oncomatrix; Pharmacyte Biotech; Sumitomo Group; Takeda
Consulting or Advisory Role - Agenus; Bayer; Oncomatrix; Pharmacyte Biotech; Takeda
Research Funding - BiolineRx; ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - Royalties from Myriad for PALB2 patent
Expert Testimony - Myriad Genetics
Travel, Accommodations, Expenses - BiolineRx
 
Joseph Elan Grossman
Employment - Agenus
 
Remigiusz Kaleta
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
David M. O'Malley
Consulting or Advisory Role - Abbvie; Agenus; Ambry Genetics; AstraZeneca; Clovis Oncology; Eisai; Elevar Therapeutics; Genelux; Genentech/Roche; GlaxoSmithKline; GOG Foundation; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Leap Therapeutics; Marker Therapeutics; Myriad Genetics; Novartis; Novocure; OncoQuest; Regeneron; Rubius Therapeutics; Rubius Therapeutics; Seagen; Sorrento Therapeutics; Tarveda Therapeutics; Tesaro; Translational Genomics Research Institute
Research Funding - Abbvie (Inst); Abbvie/Stemcentrx (Inst); Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); Eisai (Inst); Eisai (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Genmab (Inst); Immunogen (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Janssen Research & Development (Inst); Leap Therapeutics (Inst); Merck (Inst); Mersana (Inst); PharmaMar (Inst); Regeneron (Inst); Seagen (Inst); Tesaro (Inst); TRACON Pharma (Inst)